Fig. 2: Functional serum IgG levels over time after treatment initiation up to 6 months of follow up.
From: Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
The x-axis represents individual patients. The colored bars report the number of days within the 1st 6-months during which each patient experienced functional hypogammaglobulinemia (IgG < 400 mg/dL) or non-hypogammaglobulinemia (IgG ≥ 400 mg/dL).
